PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Refining Value in Pharma

Avoiding a Corporate Integrity Agreement: Analytics and the Search for Dangerous Data

Charting an Effective Big Data Strategy

Advertisement
Top Story
Value Frameworks in the US: Not an Echo Chamber
In the second of her articles on value assessment, Leela Barham discusses the emergence of multiple frameworks in the US and considers their impact
/Read more/
Advertisement
National Pharmacy Market Summary - Market Insights Report
A listing of the top 50 largest acute care hospitals in the US; ranked by size and specialty rank. Learn about QuintilesIMS Top 50 Largest U.S. Acute Care Hospitals, States Ranked by Count of Acute Care Hospitals & Staffed Beds, Acute Care Hospitals by Specialty Type, and More….Read it Today!
Sponsored by Quintiles IMS
Opinion
STEM: Helping Women Advance from Bench to Boardroom
Female students pursuing a Science, Technology, Engineering, and Mathematics (STEM) pathway need earlier enticement and more C-suite role models, writes Mylan's Head of Global Commercial Development, Adele Gulfo
/Read more/
Advertisement
Simplify complex global transparency and disclosure needs
A leading pharmaceutical company was faced with the challenge of providing a single view across their enterprise to gain a greater understanding of the amount of money and resources being allocated across all business units. They found their answer in an end-to-end, configurable compliance data management and reporting solution.
Sponsor: LexisNexis(R) Health Care
Learn more
Oncology
mAb Biosimilars: The Future of Cancer Treatment?
Time will determine the shape of biosimilar usage in oncology, but they will play a significant role in the battle against cancer in the future, writes Alessandra Franceschetti
/Read more/
Advertisement
Unlocking the Patient Voice: How Digital Technology Can Facilitate Effective Patient Data Capture in Real-World Data Programs
On Demand
Learn more
Healthcare Communications
Syncing Social Media with a Value-Care Model
Julian Suchman writes that while it's easy to get excited about new gadgets, the overall goal of mHealth and social media must be to deepen relationships and communication
/Read more/
Advertisement
Through the Patient's Eyes - Needs, Behaviors and the Science Behind it All
On Demand
Learn more
Pricing
Controversial 340B Drug Discounts Linked to Drug Pricing Issues
Pharma companies have been protesting expansion of the federal program that provides deeply discounted prescription drugs to certain hospitals and health providers serving low-income, uninsured patients
/Read more/
Advertisement
Driving Great Access to Healthcare Professional and Increasing Brand Performance How Virtual Engagement is Becoming a Must Have Component of any Pharmaceutical Sales Strategy
Sponsored by TrialCard
Download Whitepaper
Calendar
/ August 8–9: Bio/Pharma Strategic Portfolio Management Summit /
Cambridge, MA
/ August 14–16: 11th Annual Forum on Transparency & Aggregate Spend /
Washington, DC
/ August 16–17: Reimbursement and Access /
Philadelphia, PA
/ August 22–23: Bio/Pharma Forum on Data Science /
Philadelphia, PA
/ September 14-15, 2017: Compliance Congress for Specialty Products /
Boston, MA
/ September 14–15: Risk Based Global Monitoring 2017 /
Barcelona, Spain
/ October 24–25: 12th Annual Value-Based Oncology Management /
Scottsdale, AZ
/ December 12–13: Patient Journey Mapping: From Diagnosis to Treatment /
Philadelphia, PA
/ February 27–28, 2018: Speaker Programs 2018 /
Philadelphia, PA
Advertisement
The Changing Market for Drugs to Treat Orphan Diseases
On Demand
Learn more
Industry update
//Bicycle Therapeutics (Cambridge, MA and Cambridge, UK) appointed Lee Kalowski as Chief Financial Officer. //Evolve BioSystems (Davis, CA) named Timothy B. Brown as CEO. Mr. Brown will also join the company's Board of Directors. //BlackThorn Therapeutics (South San Francisco, CA) announced the appointment of Matthew K. Fust to the company’s Board of Directors. //Clinical-stage gene therapy company NightstaRx Limited (Boston, MA and London, UK) named Tuyen Ong, M.D., MRCOphth, MBA, as Executive Vice President and Chief Development Officer. //
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com